| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/27/2008 | US7378496 kits for prognosis and treatment regimen of a subject having or at risk for neuropsychiatric, neurological, neuromuscular, and immunological disorder |
| 05/27/2008 | US7378495 PTH-rP related peptide cancer therapeutics |
| 05/27/2008 | US7378494 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide |
| 05/27/2008 | US7378493 Expression vector comprising nucleotide sequences coding insecticidal proteins for use in transformation and propagation of insect resistant crop plants; biological pest control |
| 05/27/2008 | US7378492 CD40-related receptor that binds CD40L |
| 05/27/2008 | US7378491 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378487 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378445 Treatment of prostate cancer |
| 05/27/2008 | US7378395 Administering deletion mutant of a transforming growth factor beta super family member; deletion mutant has an ossification inhibiting mutation |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378392 Bone and cartilage inductive proteins |
| 05/27/2008 | US7378390 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 05/27/2008 | US7378389 Neurotoxic component has been purified from a botulinum toxin by fermenting a Clostridium botulinum to botulinum toxin type A; promotion of normal muscle growth |
| 05/27/2008 | US7378384 X-Y-Thr-Trp-Asn-Gln-Met-Asn-Leu wherein X represents Ser, Ala, Abu, Arg, Lys, Orn, Cit, Leu, Phe, or Asn, and Y represents Tyr or Met; cysteine residue is substituted with a defined amino acid residue; cancer vaccines |
| 05/27/2008 | US7378275 Canine IL-13 receptor alpha-1 subunit nucleic acid molecules |
| 05/27/2008 | US7378274 Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses |
| 05/27/2008 | US7378258 Antibodies; transcription regulators; bacterial infections; vectors; host cells |
| 05/27/2008 | US7378257 Immunoglobulin fusion comprising bacterial toxin for use in prevention and treatment of bacterial infection; bactericides; microbiocides; genetic vaccines |
| 05/27/2008 | US7378253 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 05/27/2008 | US7378252 Signal transduction |
| 05/27/2008 | US7378251 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein |
| 05/27/2008 | US7378247 Tumor preferential polypeptide for use in the prevention treatment and diagnosis of cell proliferative disorders |
| 05/27/2008 | US7378246 Methods and compositions for regulating adipogenesis |
| 05/27/2008 | US7378234 Method for isolating hepatitis C virus peptides |
| 05/27/2008 | US7378219 Optical information carrier comprising immobilized proteorhodopsin |
| 05/27/2008 | US7378101 Immunogenic mixture comprising porphyromonas inactivated whole cell preparation for use in generating immunotherapeutic protein for prevention and treatment of oral disease in companion animals |
| 05/27/2008 | US7378099 Human papillomavirus polypeptides and immunogenic compositions |
| 05/27/2008 | US7378098 CXC chemokine receptor 4 agonist peptides |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | US7378095 Methods of treating type I diabetes by blocking VEGF-mediated activity |
| 05/27/2008 | US7378093 Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes |
| 05/27/2008 | US7378090 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical PKM activity |
| 05/27/2008 | US7378087 Method of enhancing an immune response |
| 05/27/2008 | US7378080 Detection, measurement, calibration gene expression |
| 05/27/2008 | CA2413629C Solid method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/27/2008 | CA2322616C A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 05/27/2008 | CA2275974C Methods for producing parthenocarpic or female sterile transgenic plants |
| 05/27/2008 | CA2258494C Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 05/27/2008 | CA2213813C Methods and compositions for secretion of heterologous polypeptides |
| 05/27/2008 | CA2145641C Pseudo-adenovirus vectors |
| 05/27/2008 | CA2120358C Hormone analogs with multiple ctp extensions |
| 05/27/2008 | CA2117181C Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 05/22/2008 | WO2008060941A2 Expression system of nell peptide |
| 05/22/2008 | WO2008060811A2 Peptides facilitating or inhibiting anterograde transport |
| 05/22/2008 | WO2008060785A2 Prevention of tissue ischemia, related methods and compositions |
| 05/22/2008 | WO2008060780A2 Glycerol linked pegylated sugars and glycopeptides |
| 05/22/2008 | WO2008060702A2 Replikin peptides and uses thereof |
| 05/22/2008 | WO2008060634A2 Human complement c3 derivatives with cobra venom factor-like function |
| 05/22/2008 | WO2008060597A2 Compounds useful as protein kinase inhibitors |
| 05/22/2008 | WO2008060510A2 Zinc finger nuclease for targeting the human glucocorticoid receptor locus |
| 05/22/2008 | WO2008060219A1 Il- 18 vaccine for the treatment of various inflammatory conditions. |
| 05/22/2008 | WO2008059996A2 Agent that modulates physiological condition of pests, involved in insect vesicle-fusing atpase activity |
| 05/22/2008 | WO2008059927A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | WO2008059553A1 Method for detecting hiv-1 without being affected by anti-mouse protein antibody existing in human and kit to be used for the same |
| 05/22/2008 | WO2008059314A1 Malaria vaccine based on the 200l subunit of the plasmodium vivax msp1 protein |
| 05/22/2008 | WO2008059066A1 New chemokine derivatives of ccl14, synthesis and use as drugs for the treatment of allergic diseases |
| 05/22/2008 | WO2008059043A2 Combination of coagulation factor viii with apc-resistant factor v |
| 05/22/2008 | WO2008059011A1 Artificial binding proteins based on a modified alpha helical region of ubiquitin |
| 05/22/2008 | WO2008059005A2 Novel sequences of haemonchus contortus, immunogenic compositions, methods for preparation and use thereof |
| 05/22/2008 | WO2008058942A2 Method of cell culture and method of treatment comprising a vepo protein variant |
| 05/22/2008 | WO2008058922A1 Marker specific to an oxidation degradation of tissues containing type iii collagen, means and methods, and kits for the tracking diagnosis or prognosis of pathologies targeted by said marker |
| 05/22/2008 | WO2008058547A2 Alpha-lactalbumin composition |
| 05/22/2008 | WO2008058461A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | WO2008058399A1 Methods for diagnosis, prognosis or treatment of migraine and related disorders |
| 05/22/2008 | WO2008058396A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | WO2008058384A1 Materials and methods for prognosing lung cancer survival |
| 05/22/2008 | WO2008058369A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | WO2008058342A1 Compounds, compositions and methods for controlling invertebrate pests |
| 05/22/2008 | WO2008058302A1 S-layer protein covered surfaces |
| 05/22/2008 | WO2008041231A3 MEMBRANE-ANCHORED β2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES |
| 05/22/2008 | WO2008039843A3 Novel peptides that promote lipid efflux |
| 05/22/2008 | WO2007136685A3 Methods and compositions for inactivation of dihydrofolate reductase |
| 05/22/2008 | WO2007132175A3 Inhibitors of hcap18/ll-37 for use in the treatment of breast cancer |
| 05/22/2008 | WO2007109747A3 Methods and compositions for antagonism of rage |
| 05/22/2008 | WO2007062656A3 A nucleotide vaccine |
| 05/22/2008 | WO2007054090A8 Therapeutic vaccines targeting hmgb1 |
| 05/22/2008 | WO2006059913A9 Modulation of ovulation |
| 05/22/2008 | WO2005110009A8 COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d |
| 05/22/2008 | US20080120751 Expression vector comprising nucleotide sequences coding expressed sequences tags for use in generation of disease, heat , drought and insect resistant plants |
| 05/22/2008 | US20080119685 Methods for modulating checkpoint activation through TopBP1 |
| 05/22/2008 | US20080119641 Immunoglobulin specific to junction-enriched and -associated proteins (JEAP) for use in identifying proteins localized at cell-to-cell junctions; fluorescence-labeled protein localization |
| 05/22/2008 | US20080119640 Human Interferon Molecules and Their Uses |
| 05/22/2008 | US20080119639 Recombinant polypeptide for confering glyphosate resistance to crops; herbicide resistant plants |
| 05/22/2008 | US20080119638 Human endothelin receptor |
| 05/22/2008 | US20080119636 Methods and materials for cancer treatment |
| 05/22/2008 | US20080119569 Polymer-based sustained release device |
| 05/22/2008 | US20080119542 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119412 Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins |
| 05/22/2008 | US20080119411 use of salmon calcitonin in combination with PTH for the oral administration of PTH for the treatment of osteoporosis without the potentially toxic hypercalcemic side effects |
| 05/22/2008 | US20080119406 caltrin or functionally active peptide fragment together with a pharmaceutically acceptable carrier; osteroporosis, osteoarthritis, Paget's disease, osteomalacia, prolonged bed rest, chronic disuse of a limb, anorexia, microgravity, exogenous and endogenous gonadal insufficiency, bone fracture |
| 05/22/2008 | US20080119405 Fowlicidins and Methods of Their Use |
| 05/22/2008 | US20080119404 angiopoietin-related growth factor used as antiobesity agent, an antidiabetic agent, and/or a hypolipidemic agent; polypeptides |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080119401 A polypeptide produced by the parathyroid glands using such analogues alone or in combination with a bisphosphonate or calcitonin to treat osteoporosis |
| 05/22/2008 | US20080119400 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/22/2008 | US20080119399 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 05/22/2008 | US20080119396 TGF analogs/promoter that bind to and neutralize cystine knot-containing BMP antagonists such as the CAN subfamily of Cystine-knot proteins including sclerostin and promotes bone growth and mineralization in vivo; |